High-performance invasive brain-computer interface nears clinical validation stage
According to Li, by working with Peking University First Hospital, Xuanwu Hospital Capital Medical University and Beijing Tiantan Hospital of the Capital Medical University, Neucyber Neurotech has finished five Beinao-1 implantation operations since the beginning of 2025, delivering motor and speech rehabilitation and functional substitution for individuals with spinal cord injuries, stroke, or amyotrophic lateral sclerosis.
Beinao-1 is the world's first high-throughput wireless fully implanted BCI system and is an electroencephalogram-based BCI system.
"Next, we will complete the official registered clinical trial for the Beinao-1 intelligent BCI system, continuing to advance technological optimization and application expansion, bringing hope to more patients," Li added.
- First-ever cross-boundary torch relay held for National Games
- New cultural landmark starts trial operation in Shenzhen
- China, Russia to deepen practical cooperation in humanities cooperation
- New quality productive forces gather steam to turbocharge future growth
- Shenzhen named host city for APEC 2026 as China champions cooperation, green growth
- China to launch new-generation crewed spaceship in 2026
